Pharma companies are being asked a difficult question: What is the environmental impact of a medicine — and how can that insight support better decisions?
Answering that question is complex. Product sustainability assessments in pharma must account for fragmented supply chains, limited primary data, evolving expectations and sector-specific methodological challenges. Generic LCA approaches often struggle to reflect the realities of pharmaceutical products.
In this webinar, Sphera’s pharma sustainability experts will discuss how companies can build more credible, scalable and decision-ready product sustainability assessments.
You will gain insights into:
- Key market and regulatory drivers shaping pharma sustainability
- Practical lessons from PAS 2090 and its application in the sector
- Common pharma LCA challenges, hotspots and methodological considerations
- The role of high-quality primary data and pharma-specific databases
- How scalable approaches can help move from one-off assessments to portfolio-level insights
Join us to explore how pharma organizations can turn product sustainability data into insights that support strategy, compliance, portfolio decisions and innovation.
Featured speakers
Hear from Sphera experts who bring hands-on experience in pharmaceutical sustainability, product LCA, carbon footprinting, data strategy and scalable assessment approaches.
